Understanding Fibromyalgia and Differential Diagnosis

Fibromyalgia is a functional condition that affects voluntary muscles, commonly presenting in females aged 20-40 years. It is characterized by multiple trigger points over soft tissues in the neck, intrascapular region, and spine, along with poor sleep patterns and fatigue. While there is no known cure, patients are encouraged to establish a regular sleep pattern and participate in a graded exercise program. Differential diagnosis is important to exclude other rheumatological conditions that may present similarly but have different treatment options. Polymyalgia rheumatica, polymyositis, hypothyroidism, and systemic lupus erythematosus are some of the conditions that need to be ruled out. Steroids are the mainstay of treatment for polymyalgia rheumatica, while hypothyroidism presents with different symptoms such as constipation, dry hair, and weight gain. Systemic lupus erythematosus typically presents with a butterfly rash over the face and other symptoms such as anaemia, pleuritic chest pain, and haematuria.

Systemic lupus erythaematosus (SLE) is an autoimmune disease where the body produces autoantibodies against various antigens, leading to the formation of immune complexes that can deposit in different parts of the body, such as the kidneys. Symptoms of SLE include fatigue, joint pain, rash, and fever. Diagnosis of SLE requires the presence of at least four out of eleven criteria, including malar rash, discoid rash, photosensitivity, oral or nasopharyngeal ulceration, arthritis, serositis, renal disorder, CNS disorders, haematological disorders, positive immunology, and positive ANA. Anti-double-stranded DNA (dsDNA) antibody is highly specific for SLE but only positive in 60% of patients. Other antibodies, such as anti-La antibodies, rheumatoid factor IgG, ANCA, and Scl70, are raised in other autoimmune diseases such as Sjögren’s syndrome, rheumatoid arthritis, and various vasculitides.

Common Foot Injuries and Their Characteristics

Lisfranc injury is a type of foot injury that occurs when one or more metatarsal bones are displaced from the tarsus. This injury is usually caused by excessive kinetic energy being placed on the midfoot, such as in a traffic collision. There are two types of Lisfranc injuries: direct and indirect. A direct injury occurs when the foot is crushed by a heavy object, while an indirect injury occurs when there is sudden rotational force on a plantar flexed foot.

March fracture is another common foot injury that is caused by repetitive stress on the distal third of one of the metatarsal bones. This injury is often seen in soldiers and hikers who walk long distances. The onset of foot pain is gradual and progressive, and there is often trauma associated with it.

Hallux Rigidus is a degenerative arthritis that causes bone spurs at the metatarsophalangeal joint of the big toe, making it painful and stiff. Jones fracture is a fracture in the meta-diaphyseal junction of the fifth metatarsal of the foot. Proximal fifth metatarsal avulsion fracture is caused by forcible inversion of the foot in plantar flexion, such as when stepping on a kerb or climbing steps.

These different foot injuries have their own unique characteristics and causes. these injuries can help individuals take preventative measures to avoid them and seek appropriate treatment if necessary.

Differentiating between Elevated Serum Markers in a Patient with Arthropathy and Hilar Lymphadenopathy

The presence of arthropathy and hilar lymphadenopathy in a patient can be indicative of various underlying conditions. In this case, the patient’s elevated serum markers can help differentiate between potential diagnoses.

Elevated serum angiotensin-converting enzyme (ACE) is a common finding in sarcoidosis, which is likely the cause of the patient’s symptoms. Bilateral hilar lymphadenopathy with or without pulmonary fibrosis is the most typical radiological sign of sarcoidosis. Additionally, acute arthropathy in sarcoidosis patients, known as Löfgren syndrome, is associated with erythema nodosum and fever.

On the other hand, elevated cytoplasmic anti-neutrophil cytoplasmic antibody (c-ANCA) is present in granulomatosis with polyangiitis (GPA), which presents with necrotising granulomatous lesions in the upper and lower respiratory tract and renal glomeruli. It is not typically associated with hilar lymphadenopathy.

Hyperuricaemia and elevated double-stranded (ds) DNA antibody are not relevant to this case, as they are not associated with the patient’s symptoms. Hyperglycaemia is also not a factor in this case.

In conclusion, the combination of arthropathy and hilar lymphadenopathy can be indicative of various underlying conditions. Elevated serum markers can help differentiate between potential diagnoses, such as sarcoidosis and GPA.

The patient in this scenario has systemic lupus erythematosus (SLE) with mild symptoms, primarily affecting the joints and skin. The first-line treatment for this type of SLE is hydroxychloroquine, which can induce remission and reduce recurrence. However, patients on this medication must be monitored for drug-induced retinopathy. Methotrexate may be used in more severe cases with active joint synovitis. Sun avoidance is important to prevent flares, but it is not enough to treat the patient’s current symptoms. Infliximab is not typically used to treat SLE, and rituximab is reserved for last-line therapy. Azathioprine is commonly used as a steroid-sparing agent in SLE, but hydroxychloroquine is more appropriate for this patient’s current presentation. The main adverse effect of azathioprine is bone marrow suppression, which can be life-threatening in some patients.

Treatment Options for Acute Gout Flare in a Patient with Peptic Ulcer Disease

When managing an acute gout flare in a patient with a history of peptic ulcer disease, it is important to consider the potential risks and benefits of different treatment options. Colchicine and non-steroidal anti-inflammatory drugs (NSAIDs) are both effective first-line treatments, but NSAIDs should be used with caution in patients with a history of peptic ulcer disease. If NSAIDs are used, proton-pump cover should be provided for gastric protection. Allopurinol should not be started until after the acute attack has been resolved, and paracetamol may be used as an adjunct for pain relief but would not treat the underlying cause of pain. Prednisolone may be used in patients unable to tolerate NSAIDs or colchicine, but there is no contraindication to a trial of oral colchicine in this patient. Overall, the choice of treatment should be individualized based on the patient’s medical history and preferences.

Diagnostic Markers for Polymyalgia Rheumatica and Temporal arthritis

Polymyalgia rheumatica and temporal arthritis are inflammatory conditions that can cause significant morbidity if left untreated. Here are some diagnostic markers that can help support or rule out these conditions:

Plasma viscosity: A raised plasma viscosity can support a diagnosis of polymyalgia rheumatica with temporal arthritis, but it is a nonspecific inflammatory marker.

Creatine kinase: A raised creatine kinase is not supportive of a diagnosis of polymyalgia rheumatica or temporal arthritis.

Monospot test: A positive monospot test is supportive of a diagnosis of Epstein–Barr virus (EBV), but not polymyalgia rheumatica or temporal arthritis.

Whole cell count (WCC): A raised WCC is not supportive of a diagnosis of polymyalgia rheumatica or temporal arthritis.

Bence Jones proteins: Presence of Bence Jones protein is supportive of a diagnosis of multiple myeloma, but not polymyalgia rheumatica or temporal arthritis.

If temporal arthritis is suspected, immediate treatment with prednisolone is crucial to prevent permanent loss of vision. A temporal artery biopsy can confirm the diagnosis.

Systemic lupus erythematosus (SLE) is an autoimmune disorder that predominantly affects young women. It is characterized by a photosensitive butterfly-shaped rash on the face and joint manifestations. Unlike rheumatoid arthritis, SLE does not cause severe destruction of joints. SLE is a multisystem condition that can affect many systems, including haematological, renal, respiratory, and cardiac systems. The underlying pathological mechanism of damage in SLE is immune complex deposition, which produces antibodies against several nuclear components of the body, especially against double-stranded DNA (dsDNA). Antinuclear antibodies (ANA) and dsDNA are associated with SLE, as is a low C3 and C4. The immunoglobulin, C3 and fibrinogen deposits found in this patient are classic of the immune complex deposition seen in SLE.

Common Hand and Wrist Pathologies

The hand and wrist are common sites of pathology, particularly in postmenopausal women. Osteoarthritis frequently affects the first carpometacarpal joint, causing tenderness, stiffness, crepitus, swelling, and pain on thumb abduction. This can lead to squaring of the hand, radial subluxation of the metacarpal, and atrophy of the thenar muscles.

Scaphoid fractures are also relatively common, often resulting from a fall onto an outstretched hand. The proximal portion of the scaphoid lacks its own blood supply, which can lead to avascular necrosis if a fracture isolates it from the rest of the bone. This produces pain and tenderness on the radial side of the wrist, typically in the anatomical snuffbox, worsened by wrist movement.

De Quervain’s tenosynovitis is another common pathology, characterized by stenosing tenosynovitis of the first dorsal compartment of the wrist. It presents with pain, swelling, and tenderness on the radial aspect of the wrist. Treatment typically involves splinting, with or without corticosteroid injection.

Treatment Options for Rheumatoid Disease: A Comparison of Biological Therapies and DMARDs

Rheumatoid disease can be a debilitating condition that requires careful management. When standard disease-modifying anti-rheumatic drugs (DMARDs) fail to provide relief, biological therapies may be prescribed. Infliximab, adalimumab, and etanercept are some of the contemporary biological therapies available. Infliximab, in particular, is often co-prescribed with methotrexate, although it may cause a reversible lupus-like syndrome and tuberculosis reactivation.

Combining gold, leflunomide, and methotrexate is unlikely to help patients who have already failed DMARD therapy. Azathioprine may be considered in severe cases, but biological therapy is the preferred treatment when intensive DMARD therapy fails. The combination of gold and penicillamine is a viable option for patients who meet the criteria for biological therapy, according to National Institute for Health and Care Excellence (NICE) guidelines. DMARD monotherapy, such as leflunomide, is only recommended when dual therapy is contraindicated.

In summary, the choice of treatment for rheumatoid disease depends on the severity of the condition and the patient’s response to previous therapies. Biological therapies may offer relief for patients who have failed DMARD therapy, but careful monitoring for potential side effects is necessary.